Key Takeaways
- Record year, capacity-constrained quarter: FY26 delivered highest-ever revenue, EBITDA and profit while utilization exceeded 120%, but the company is turning away business because it cannot produce more until the new plant opens.
- Three-year doubling ambition, conservatively framed: Management guides ₹200 cr / ₹250 cr / ₹300 cr for FY27–29, a path that doubles revenue from the ₹152 cr FY26 base, and explicitly prefers under-promising.
- New facility is the entire growth story for FY27: The YEIDA plant, delayed by stainless steel and manpower shortages at a local fabricator, is now expected to start commercial operations in August 2026 and will contribute ₹40–50 cr of incremental revenue this year.
- Margins held at 26% EBITDA despite 120%+ utilization: Operating costs rose only 4% while turnover jumped, so fixed-cost amortization drove the 441 bps expansion; management hopes to hold similar margins even as depreciation rises with the new plant.
- What to watch next quarter: Whether the YEIDA plant actually starts in July (management’s stretch target) or slips further toward the official August date, and any signal on the pace of ramp-up once commercial production begins.
The Capacity Wall
- Utilization has no headroom left: The company operated above 120% capacity utilization in FY26 and management acknowledged it is unable to entertain many customer opportunities because of the constraint.
- H1 FY27 growth must come from the same stretched base: With the new facility not contributing until August at the earliest, the first half relies entirely on sustaining the existing 120%+ run-rate; management declined to give a first-half breakdown when pressed.
- The delay was a local supply-chain problem: Civil work is complete and the plant machinery has arrived from Holland, but stainless steel fabrication by a domestic manufacturer stalled due to non-availability of a specific steel grade and manpower shortages, a delay management called beyond its control.
- Once it starts, it starts at full capacity: Management stated there will be no issue procuring raw materials or manpower, and the plant will begin commercial production at full rated capacity rather than a slow commissioning ramp.
- Utilization guidance is off the table: When asked for a ballpark capacity utilization figure across FY27–FY29, management flatly declined, promising only to do their best.
Manoj Arora: "What is good? Giving the conservative or making some, you know, claim? So I, we do not want that any of our promise made to you fails."
The YEIDA Facility & the Capex Bet
- ₹76.59 cr invested so far out of a total project capex of ₹184 cr, funded by ₹28.79 cr from IPO proceeds and ₹47.80 cr from internal accruals; the company remains debt-free and will draw ~₹60 cr of debt only as needed.
- Capacity will multiply 4x once the new plant is fully operational, and the company has used only half the land, leaving room for further expansion in coming years if demand warrants.
- Incremental revenue math: Management expects ₹40–50 cr from the new facility in FY27 and an additional ₹50 cr in FY28, implying roughly ₹100 cr total contribution by the second year of operation.
- Asset turnover will compress sharply: Per an analyst’s math, the ₹184 cr capex on a ~₹152 cr revenue base implies asset turnover falling from ~6.6x toward ~1.5x; management acknowledged the correlation with topline growth but declined to model it, leaving the assumption to analysts.
- Product mix will balance value and volume: The company plans to use the new capacity for products that may be cheaper to drive utilization, while also focusing on high-value, high-value-addition products.
Demand & Market Position
- Structural tailwinds are intact: Rising consumption, evolving consumer preferences, increasing product differentiation in FMCG, and demand for superior sensory experiences are all driving the fragrance and flavor market.
- The company is tiny relative to the opportunity: Management emphasized that even at ₹152 cr, Sacheerome is a very small player in a large and growing market, and that small size means a long runway for growth.
- India’s global perception is shifting in the industry’s favor: Management believes global customers are now taking Indian companies more seriously, creating an opening the company intends to exploit at the World Perfumery Congress in California this June.
- Export mix fell on paper only: The export share dropped from 7.6% to 6% of revenue, but this was because domestic revenue grew faster; export volumes and quantities both increased year-on-year.
- The order pipeline is healthy and customer demand remains strong, according to management, though no backlog or pipeline value was quantified.
Manoj Arora: "If you look at the market size of the fragrance and flavor, we are still very tiny, honestly speaking. We are very small. Okay? And when you are small, then there is a huge scope of growth available for you."
Margins & Efficiency
- FY26 margin expansion was leverage-driven: EBITDA margin expanded 441 bps to 26.02% and net profit margin improved 348 bps to 18.2%, achieved because operating costs grew only 4% while revenue jumped, amortizing fixed costs over a larger base without additional investment.
- Working capital transformation: The cash conversion cycle collapsed from 109 days to 35 days over three years, driven by better inventory and receivables management, client selection, payment safety, and a significant reduction in payable days.
- Margin outlook is steady, not expanding: Management hopes to maintain similar operating margins going forward, but flagged that higher depreciation from the new plant will be a headwind; they declined to model EBITDA margins beyond FY28.
- No separate plant-level margin disclosure: When asked what margin the new plant would earn at ₹50 cr revenue, management deflected, stating there will be one consolidated balance sheet and reiterating the hope to sustain overall operating margins.
Segments, Innovation & the Flavour Bet
- Flavours are the growth accelerator: Management stated the new facility will remove all constraints and the flavours segment will grow “very, very fast,” with multiple development projects, product approvals and commercial launches in the pipeline.
- Flavour margins are not separately disclosed: When an analyst suggested flavours carry higher margins than fragrances, management said both segments enjoy similar margins and did not confirm any premium.
- R&D is embedded, not sold separately: The company spends 2.3% of sales on R&D and its proprietary technologies (Sach maxiCaps, Sach-Autocon) are embedded into products to give a competitive edge; management cannot quantify their standalone revenue contribution.
- Innovation is demographic and trend-driven: R&D targets solutions tailored by demography, geography, gender, age group, income group and emerging consumer trends.
- No new product categories planned: The company will remain in fragrances and flavours only, but will add new segments within those categories, though management did not specify which ones when asked.
Manoj Arora: "These are the things which have which have changed completely mindset of the consumer consumers. And this is the -- we have just touched that tip of the iceberg, let me tell you, that I can tell you."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue | ₹200 cr | FY27 |
| Revenue | ₹250 cr | FY28 |
| Revenue | ₹300 cr | FY29 |
| YEIDA commercial operations | Start of production | August 2026 (stretch target July 2026) |
| Incremental revenue from new plant | ₹40–50 cr | FY27 |
| Incremental revenue from new plant (cumulative) | ~₹100 cr total | By end of FY28 |
| Operating margin | Maintain ~25%+ level, subject to depreciation and geopolitics | FY27 and ongoing |
| Capacity utilization | Management declined to provide any figure | FY27–FY29 |
| EBITDA margin beyond FY28 | Management declined to answer | Beyond FY28 |
Key Metrics
| Metric | FY26 |
|---|---|
| Total income (full year) | ₹156.29 cr, +43.9% YoY |
| Revenue from operations (full year) | ₹152.39 cr, +41.71% YoY; ₹13.61 cr from new customers, ₹31.24 cr from existing |
| EBITDA (full year) | ₹40.66 cr, +73.3% YoY; margin 26.02%, expanded 441 bps |
| Net profit (full year) | ₹28.44 cr, +78% YoY; margin 18.2%, improved 348 bps |
| Total income (H2 FY26) | ₹78.06 cr, +35.6% YoY |
| EBITDA (H2 FY26) | ₹19.56 cr, +48.8% YoY; margin 25.06%, improved 223 bps |
| Net profit (H2 FY26) | ₹13.50 cr, +51.2% YoY; margin 17.3% vs 15.5% |
| Operating margin (EBIT, full year) | ~25% |
| Revenue guidance FY27 | ₹200 cr |
| Revenue guidance FY28 | ₹250 cr |
| Revenue guidance FY29 | ₹300 cr |
| Capacity utilization | ~124%, operating above 120% |
| Domestic vs export revenue mix | ~94% domestic, ~6% export |
| Fragrance vs flavor revenue mix | ~94% fragrance, ~6% flavor |
| Export revenue | ~₹9.5 cr, up from ~₹8 cr in FY25; volume increase of 20–25% |
| R&D spend | 2.3% of total sales |
| YEIDA facility total capex | ₹184 cr; ₹76.59 cr invested as of 31 Mar 2026 (₹28.79 cr from IPO, ₹47.80 cr from internal accruals) |
| YEIDA facility debt planned | ~₹60 cr |
| Cash conversion cycle | 35 days, improved from 109 days three years ago |
| Fixed asset base FY26 | ₹23 cr; asset turnover 6.6x |
| Total asset base post YEIDA capex | ₹208 cr (₹23 cr + ₹185 cr) |
| Asset turnover post capex (FY28/FY29) | ~1.5x (per an analyst's math) |